News

Researchers have developed and used an upgraded tumor model that mimics bone to find that the body’s immune response can make tumor cells more resistant to chemotherapy.

A new substance has proven useful for treating staphylococcus infections in people with skin lymphoma. This is good news for the patients, but also for the global threat of antibiotic resistance.

In a new study, scientists show the commanding role of a specialized group of proteins in the nuclei of our cells, called mSWI/SNF (or BAF) complexes, both in activating T cells to attack cancer and triggering exhaustion.

A new technique that combines highly detailed, real-time images of inside the body with a type of infrared light has, for the first time, been used during surgery to differentiate between cancerous tumors and healthy tissue.

A new study identifies a set of biomarkers that could help clinicians to predict whether pancreatic cysts will remain benign or develop into cancer.

A new study reveals the mechanisms responsible for the development of tumor resistance to a new drug, the first approved inhibitor against the KRAS oncogene.

With chatbots and AI becoming popular resources, researchers have evaluated the reliability and accuracy of chatbots when it comes to cancer information.

A targeted therapy that combines two different drugs has been shown to be effective at reducing the size and number of non-small cell lung cancer tumors in mice.

The mechanism behind how tyrosine kinase inhibitors – a class of cancer drug – cause serious inflammatory side effects has been revealed by a new study.

A new study has shown that targeting macrophages could improve immunotherapy for some breast cancers, also revealing distinct immune cell “neighborhoods” associated with good patient outcomes.